-
Decision aid to guide healthcare professional-patient discussions on sleeping pill prescriptions published
Patient decision aid on medicines associated with dependence or withdrawal symptoms published
-
Reducing radiotherapy for some breast cancer patients is likely to have released thousands of appointments for the NHS without compromising safety, NICE finds.
Delivering fewer radiotherapy sessions over a shorter period of time, first introduced during COVID, benefits patients and the system long-term and is now enshrined in NICE guidance.
-
One-stop-shop for AI and digital regulations for health and social care launched
New online advice service launched to help the NHS and wider care system adopt and make use of new digital and artificial intelligence
-
First treatment to target heart condition set to benefit thousands as NICE draft guidance approves NHS use
NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.
-
145,000 people in England to have further treatment choice for preventing migraine attacks.
NICE has for the first time recommended an oral treatment for preventing migraines.
-
NICE welcomes life sciences review recommendations
NICE’s priority is to get the best care to patients fast while ensuring value for the taxpayer.
-
Testing could help prevent further strokes in people with gene variant
People who have had an ischaemic stroke or transient ischaemic attack (TIA) should have a genetic test to find out whether they can be treated with a drug which reduces the risk of further strokes, NICE has said.
-
NICE draft guidance recommends new treatment for chronic heart failure
Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE.
-
Nine treatment options to be made available for adults with depression or an anxiety disorder
Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS while further data is gathered, NICE has said.